{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:40:18Z","timestamp":1793176818849,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011912","name":"Washington University School of Medicine in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.clgc.2024.01.014","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T12:14:58Z","timestamp":1705925698000},"page":"586-592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Incidental Coronary Arterial Calcification for Cardiovascular Risk Assessment in Men With Prostate Cancer Undergoing PET\/CT Imaging"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2965-0747","authenticated-orcid":false,"given":"Preet A.","family":"Shaikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7626-6807","authenticated-orcid":false,"given":"Avira","family":"Som","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Deych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1477-2072","authenticated-orcid":false,"given":"Alison J.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Reimers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9458-0154","authenticated-orcid":false,"given":"Daniel J.","family":"Lenihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5033-6798","authenticated-orcid":false,"given":"Kathleen W.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"48","key":"10.1016\/j.clgc.2024.01.014_bib0001","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","article-title":"A population-based study of cardiovascular disease mortality risk in US cancer patients","volume":"40","author":"Sturgeon","year":"2019","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.clgc.2024.01.014_bib0002","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/JU.0000000000000714","article-title":"Cardiovascular risk in men with prostate cancer: insights from the RADICAL PC study","volume":"203","author":"Leong","year":"2020","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.clgc.2024.01.014_bib0003","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jnci\/djp404","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer","volume":"102","author":"Keating","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"27","key":"10.1016\/j.clgc.2024.01.014_bib0004","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.clgc.2024.01.014_bib0005","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/cncr.22933","article-title":"Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer","volume":"110","author":"Saigal","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clgc.2024.01.014_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0070","article-title":"Assessment and management of cardiovascular risk factors among US veterans with prostate cancer","volume":"4","author":"Sun","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clgc.2024.01.014_bib0007","unstructured":"NCCN Guidelines for Survivorship. Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=3&id=1466. Accessed December 18, 2022."},{"key":"10.1016\/j.clgc.2024.01.014_bib0008","unstructured":"NCCN Clinical Practice Guidelines in Oncology for Prostate Cancer. Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1459. Accessed December 18, 2022."},{"issue":"6","key":"10.1016\/j.clgc.2024.01.014_bib0009","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCULATIONAHA.109.192695","article-title":"Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association","volume":"121","author":"Levine","year":"2010","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.clgc.2024.01.014_bib0010","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/ejhf.1920","volume":"22","author":"Lyon","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"10.1016\/j.clgc.2024.01.014_bib0011","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups","volume":"358","author":"Detrano","year":"2008","journal-title":"New Engl J Med"},{"issue":"4","key":"10.1016\/j.clgc.2024.01.014_bib0012","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s10554-020-02111-0","article-title":"Prognostic importance of coincidental coronary artery calcification on FDG-PET\/CT oncology studies","volume":"37","author":"Mais","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.clgc.2024.01.014_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001695","article-title":"Incidentally identified coronary artery calcium on non-contrast CT scan of the chest predicts major adverse cardiac events among hospital inpatients","volume":"8","author":"Yu","year":"2021","journal-title":"Open Heart"},{"issue":"2","key":"10.1016\/j.clgc.2024.01.014_bib0014","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1148\/radiol.10100383","article-title":"Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease","volume":"257","author":"Shemesh","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.clgc.2024.01.014_bib0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijcard.2020.08.024","article-title":"Coronary and aortic calcification are associated with cardiovascular events on immune checkpoint inhibitor therapy","volume":"322","author":"Schiffer","year":"2020","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.clgc.2024.01.014_bib0016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11864-021-00846-z","article-title":"Cardiovascular toxicities of androgen deprivation therapy","volume":"22","author":"Challa","year":"2021","journal-title":"Curr Treat Options Oncol"},{"issue":"8","key":"10.1016\/j.clgc.2024.01.014_bib0017","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11936-017-0563-1","article-title":"Cardiovascular complications of androgen deprivation therapy for prostate cancer","volume":"19","author":"Gupta","year":"2017","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"23","key":"10.1016\/j.clgc.2024.01.014_bib0018","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2004325","article-title":"Oral relugolix for androgen-deprivation therapy in advanced prostate cancer","volume":"382","author":"Shore","year":"2020","journal-title":"New Engl J Med"},{"issue":"6","key":"10.1016\/j.clgc.2024.01.014_bib0019","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/JU.0000000000000384","article-title":"Cardiovascular morbidity in a randomized trial comparing GnRH agonist and GnRH antagonist among patients with advanced prostate cancer and preexisting cardiovascular disease","volume":"202","author":"Margel","year":"2019","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.clgc.2024.01.014_bib0020","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/JU.0000000000001785","article-title":"Cardiovascular events in men with prostate cancer receiving hormone therapy: an analysis of the FDA adverse event reporting system (FAERS)","volume":"206","author":"Zhang","year":"2021","journal-title":"J Urology"},{"issue":"16","key":"10.1016\/j.clgc.2024.01.014_bib0021","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1161\/CIRCULATIONAHA.121.056810","article-title":"Cardiovascular safety of degarelix versus leuprolide in patients with prostate cancer: the primary results of the PRONOUNCE randomized trial","volume":"144","author":"Lopes","year":"2021","journal-title":"Circulation"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:29:44Z","timestamp":1793176184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767324000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1558767324000144"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2024.01.014","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidental Coronary Arterial Calcification for Cardiovascular Risk Assessment in Men With Prostate Cancer Undergoing PET\/CT Imaging","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2024.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}